arrow
S

Shengyuan Yu

Chinese PLA General Hospital
H指数:44
被引数:7,965

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dysregulated Cerebellar–Subcortical–Cortical Interactions in Cluster Headache: Evidence From Edge Analysis Across Three Independent Datasets

丛集性头痛中失调的小脑-皮质下-皮质相互作用:来自三个独立数据集的边分析证据

2026-09-220
PRE
Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study

亚洲慢性偏头痛患者中70 mg erenumab的长期安全性与持续临床疗效:DRAGON III期研究的开放标签扩展研究

2026-06-170
OAAI
Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial

Eptinezumab在以亚洲人群为主的慢性偏头痛患者中的有效性与安全性:随机、双盲、安慰剂对照SUNRISE试验的结果

2025-10-150
OA
Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China

瑞美吉潘特用于成人偏头痛急性治疗:一项在中国成人中进行的第3期、多中心、开放标签、长期安全性和有效性研究

2025-10-090
OA
The global prevalence of headache disorders of public-health importance: a meta-analysis of population-based individual participant data from 41,614 adults from 17 countries

头痛类公共卫生重要疾病全球患病率的评估:一项基于来自17个国家41,614名成年人群的个体参与者数据的荟萃分析

2025-10-080
OAAI
Effects of acute sleep deprivation on the brain function of individuals with migraine: a resting-state functional magnetic resonance imaging study

急性睡眠剥夺对偏头痛患者脑功能的影响:一项静息态功能磁共振成像研究

2025-03-280
OA